HK1211473A1 - Vaccine of conferring a protective immune response to norovirus - Google Patents
Vaccine of conferring a protective immune response to norovirusInfo
- Publication number
- HK1211473A1 HK1211473A1 HK15112279.0A HK15112279A HK1211473A1 HK 1211473 A1 HK1211473 A1 HK 1211473A1 HK 15112279 A HK15112279 A HK 15112279A HK 1211473 A1 HK1211473 A1 HK 1211473A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- norovirus
- conferring
- vaccine
- immune response
- protective immune
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97338907P | 2007-09-18 | 2007-09-18 | |
US98682607P | 2007-11-09 | 2007-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1211473A1 true HK1211473A1 (en) | 2016-05-27 |
Family
ID=40468754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15112279.0A HK1211473A1 (en) | 2007-09-18 | 2015-12-14 | Vaccine of conferring a protective immune response to norovirus |
Country Status (10)
Country | Link |
---|---|
US (4) | US10130696B2 (xx) |
EP (1) | EP2190471A4 (xx) |
JP (4) | JP2010539192A (xx) |
KR (2) | KR20100083150A (xx) |
CN (2) | CN101918028B (xx) |
AU (1) | AU2008302276B2 (xx) |
CA (1) | CA2698397C (xx) |
HK (1) | HK1211473A1 (xx) |
SG (2) | SG10201601660YA (xx) |
WO (1) | WO2009039229A2 (xx) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2601970T1 (sl) * | 2006-09-29 | 2017-04-26 | Takeda Vaccines, Inc. | Formulacije cepiva proti norovirusu |
HUE028605T2 (en) | 2007-03-14 | 2016-12-28 | Takeda Vaccines Inc | Cleaning virus-like particles |
SG10201601660YA (en) | 2007-09-18 | 2016-04-28 | Takeda Vaccines Inc | Method of conferring a protective immune response to norovirus |
US20100266636A1 (en) | 2007-09-18 | 2010-10-21 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
JP5852883B2 (ja) | 2008-08-08 | 2016-02-03 | タケダ ワクチン,インコーポレイテッド | 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子 |
WO2010111586A2 (en) * | 2009-03-27 | 2010-09-30 | Arizona Board Of Regents Acting For And On Behalf Of Arizona State University | Mucosal immunization |
JP5804453B2 (ja) * | 2009-05-14 | 2015-11-04 | 国立大学法人 東京大学 | 結晶性ポリオール微粒子及びその調製方法 |
US9439958B2 (en) * | 2009-12-23 | 2016-09-13 | Arizona Board Of Regents Acting For And On Behalf Of Arizona State University | Stabilized virus like particles having enhanced mucosal immunogenicity |
WO2012006293A1 (en) * | 2010-07-06 | 2012-01-12 | Novartis Ag | Norovirus derived immunogenic compositions and methods |
FI122520B (fi) * | 2010-10-15 | 2012-03-15 | Vesna Blazevic | Noroviruksen kapsidi ja rotaviruksen VP6-proteiini käytettäväksi yhdistelmärokotteena |
CN108126204A (zh) | 2011-03-11 | 2018-06-08 | 特斯通有限责任合伙公司 | 包含组蛋白去乙酰化酶抑制剂的疫苗接种方法 |
AU2012282658B2 (en) | 2011-07-11 | 2014-11-27 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
AU2012323189A1 (en) * | 2011-10-12 | 2014-03-06 | Alpha-O Peptides Ag | Self-assembling peptide nanoparticles as vaccines against infection with norovirus |
CN102559616B (zh) * | 2012-02-24 | 2014-01-01 | 河南科技大学 | 一种含诺如病毒rna片段的假病毒颗粒及其制备方法 |
AU2013278056B2 (en) | 2012-06-21 | 2018-07-05 | Northwestern University | Peptide conjugated particles |
JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
JP2015017065A (ja) * | 2013-07-12 | 2015-01-29 | 株式会社Umnファーマ | ノロウイルスのウイルス様粒子を含む医薬組成物 |
US9017698B2 (en) * | 2013-09-25 | 2015-04-28 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
SG10202107054TA (en) | 2013-10-03 | 2021-08-30 | Takeda Vaccines Inc | Methods of detection and removal of rhabdoviruses from cell lines |
US20160310412A1 (en) | 2013-12-16 | 2016-10-27 | Takeda Pharmaceutical Company Limited | Microneedle |
CA2942234A1 (en) * | 2014-03-12 | 2015-09-17 | Glaxosmithkline Biologicals S.A. | Liposomal compositions for mucosal delivery |
AU2016317661B2 (en) * | 2015-08-28 | 2023-05-18 | Ology Bioservices, Inc. | Norovirus vaccine |
JP6977206B2 (ja) * | 2016-03-31 | 2021-12-08 | 富山県 | 自然免疫を活性化する粘膜ワクチン用アジュバント |
CN107184970A (zh) * | 2017-02-16 | 2017-09-22 | 北京生物制品研究所有限责任公司 | 口服诺如病毒亚单位疫苗及lt作为该疫苗佐剂的用途 |
JP2021514391A (ja) * | 2018-02-15 | 2021-06-10 | アイコン ジェネティクス ゲーエムベーハー | ノロウイルスに対する免疫応答を生成するための免疫原性組成物及びワクチン |
WO2020041192A1 (en) * | 2018-08-20 | 2020-02-27 | Takeda Vaccines, Inc. | Vlp formulations |
WO2022246323A1 (en) | 2021-05-21 | 2022-11-24 | Takeda Vaccines, Inc. | Solid composition, freeze-drying method and glass vial |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6572862B1 (en) | 1989-11-08 | 2003-06-03 | Baylor College Of Medicine | Methods and reagents to detect and characterize Norwalk and related viruses |
WO1992016543A1 (en) | 1991-03-25 | 1992-10-01 | Genelabs Incorporated | NORWALK VIRUS HUMAN GASTROENTERITIS AGENT AND MOLECULAR CLONING OF CORRESPONDING cDNAs |
CA2133339A1 (en) | 1992-04-08 | 1993-10-09 | Jennifer S. Rota | Wild-type measles virus glycoproteins: vaccine and detection method therefor |
US5788970A (en) | 1994-03-29 | 1998-08-04 | The University Of Maryland College Park | Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon |
ATE328068T1 (de) | 1994-05-16 | 2006-06-15 | Merck & Co Inc | Papillomavirus vakzine |
US5645051A (en) | 1995-04-21 | 1997-07-08 | Dura Pharmaceuticals, Inc. | Unit dose dry powder inhaler |
US5861241A (en) | 1995-08-16 | 1999-01-19 | University Of Massachusetts | Monoclonal antibodies for detecting Norwalk virus |
GB9525083D0 (en) | 1995-12-07 | 1996-02-07 | Danbiosyst Uk | Vaccine compositions |
US5834015A (en) | 1996-09-11 | 1998-11-10 | Albany Medical College | Protein-lipid vesicles and autogenous vaccine comprising the same |
US5953727A (en) | 1996-10-10 | 1999-09-14 | Incyte Pharmaceuticals, Inc. | Project-based full-length biomolecular sequence database |
US6491919B2 (en) | 1997-04-01 | 2002-12-10 | Corixa Corporation | Aqueous immunologic adjuvant compostions of monophosphoryl lipid A |
KR20010006169A (ko) | 1997-04-08 | 2001-01-26 | 폴락 돈나 엘. | 안정화된 사람 파필로마바이러스 제형물 |
CA2288129A1 (en) | 1997-05-01 | 1998-11-12 | Chiron Corporation | Use of virus-like particles as adjuvants |
US20040265377A1 (en) | 1997-10-27 | 2004-12-30 | Harry Seager | Solid dispersing vaccine composition for oral delivery |
CA2339034C (en) | 1998-08-14 | 2010-10-12 | Merck & Co., Inc. | Process for purifying human papillomavirus virus-like particles |
ES2262359T3 (es) | 1998-12-17 | 2006-11-16 | MERCK & CO., INC. | Particulas tipo virus sinteticas con epitores heterologos. |
EP1150712B1 (en) | 1999-02-05 | 2008-11-05 | Merck & Co., Inc. | Human papilloma virus vaccine formulations |
KR100771402B1 (ko) | 1999-06-22 | 2007-10-30 | 국립감염증연구소장이 대표하는 일본국 | Srsv 검출 킷트 |
GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
AU2003213060A1 (en) | 2002-02-14 | 2003-09-04 | Novavax, Inc. | Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
GB0206359D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
JP4902103B2 (ja) | 2002-04-11 | 2012-03-21 | メディミューン・エルエルシー | 凍結乾燥フォームによる生物活性材料の保存 |
GB0302218D0 (en) | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
EP1545625B1 (en) | 2002-06-07 | 2011-08-24 | Kentucky Bioprocessing, LLC | Flexible vaccine assembly and vaccine delivery platform |
BR0311995A (pt) | 2002-06-20 | 2005-04-05 | Cytos Biotechnology Ag | Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso |
WO2004075829A2 (en) | 2003-01-30 | 2004-09-10 | Chiron Corporation | Adjuvanted influenza vaccine |
JP2006518748A (ja) | 2003-02-20 | 2006-08-17 | ベクトン・ディキンソン・アンド・カンパニー | 改良されたワクチン接種のための大気圧噴霧凍結乾燥によって作製される組換えブドウ球菌エンテロトキシンb(<sb>r</sb>seb)の粉末処方物 |
US8592197B2 (en) | 2003-07-11 | 2013-11-26 | Novavax, Inc. | Functional influenza virus-like particles (VLPs) |
WO2005032457A2 (en) | 2003-07-21 | 2005-04-14 | Boyce Thompson Institute For Plant Research, Inc. | Vectors and methods for immunization against norwalk virus using transgenic plants |
JP2007537137A (ja) | 2003-09-24 | 2007-12-20 | モンタナ ステート ユニバーシティ | ノロウィルスモノクローナル抗体及びペプチド |
US7795242B2 (en) | 2003-10-15 | 2010-09-14 | The Brigham And Women's Hospital, Inc. | Methods and compositions for immunomodulation |
US20050215501A1 (en) | 2003-10-24 | 2005-09-29 | Coley Pharmaceutical Group, Inc. | Methods and products for enhancing epitope spreading |
FR2863890B1 (fr) | 2003-12-19 | 2006-03-24 | Aventis Pasteur | Composition immunostimulante |
US7481997B1 (en) | 2004-02-12 | 2009-01-27 | Montana State University | Snow mountain virus genome sequence, virus-like particles and methods of use |
US20050260225A1 (en) | 2004-05-18 | 2005-11-24 | Goldberg Joanna B | Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens |
CU23496A1 (es) | 2004-09-03 | 2010-02-23 | Ct Ingenieria Genetica Biotech | Composición vacunal contra el virus de la hepatitis c |
WO2006044857A2 (en) | 2004-10-20 | 2006-04-27 | Acambis Inc. | Vaccines against japanese encephalitis virus and west nile virus |
GB0428394D0 (en) | 2004-12-24 | 2005-02-02 | Chiron Srl | Saccharide conjugate vaccines |
AU2006203985A1 (en) | 2005-01-05 | 2006-07-13 | Philadelphia Health And Education Corporation | Delivery vehicles, bioactive substances and viral vaccines |
US8168771B2 (en) | 2005-01-31 | 2012-05-01 | The Johns Hopkins University | Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants |
SG164344A1 (en) | 2005-02-18 | 2010-09-29 | Novartis Vaccines & Diagnostics Srl | Immunogens from uropathogenic escherichia coli |
KR20070112225A (ko) | 2005-03-18 | 2007-11-22 | 사이토스 바이오테크놀로지 아게 | 고양이 알레르겐 컨쥬게이트 및 그의 용도 |
WO2007053188A2 (en) | 2005-06-01 | 2007-05-10 | Dow Global Technologies, Inc. | Production of multivalent virus like particles |
EP1736538A1 (en) | 2005-06-21 | 2006-12-27 | Cytos Biotechnology AG | Process for the preparative purification of virus-like-particles (VLPs) |
WO2007081447A2 (en) * | 2005-11-22 | 2007-07-19 | Novartis Vaccines And Diagnostics, Inc. | Norovirus and sapovirus antigens |
JP2007145775A (ja) | 2005-11-29 | 2007-06-14 | Falco Life Science:Kk | ノロウイルスgiの高感度検出方法 |
SI2601970T1 (sl) | 2006-09-29 | 2017-04-26 | Takeda Vaccines, Inc. | Formulacije cepiva proti norovirusu |
ES2480491T3 (es) | 2006-12-06 | 2014-07-28 | Novartis Ag | Vacunas incluyendo antígeno de cuatro cepas de virus de la gripe |
HUE028605T2 (en) | 2007-03-14 | 2016-12-28 | Takeda Vaccines Inc | Cleaning virus-like particles |
SG10201601660YA (en) | 2007-09-18 | 2016-04-28 | Takeda Vaccines Inc | Method of conferring a protective immune response to norovirus |
US20100266636A1 (en) | 2007-09-18 | 2010-10-21 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
JP5852883B2 (ja) | 2008-08-08 | 2016-02-03 | タケダ ワクチン,インコーポレイテッド | 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子 |
JP2012515752A (ja) | 2009-01-22 | 2012-07-12 | ファーマシーネ,インコーポレイテッド | 安定なワクチン組成物とその使用方法 |
CA2752039A1 (en) | 2009-02-10 | 2010-08-19 | Novartis Ag | Influenza vaccine regimens for pandemic-associated strains |
US20110070260A1 (en) | 2009-09-09 | 2011-03-24 | Baric Ralph S | Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use |
SG182636A1 (en) | 2010-01-21 | 2012-08-30 | Ligocyte Pharmaceuticals Inc | Targeted heterologous antigen presentation on calicivirus virus-like particles |
AU2011258156B2 (en) | 2010-05-26 | 2016-11-24 | Selecta Biosciences, Inc. | Multivalent synthetic nanocarrier vaccines |
AU2012282658B2 (en) | 2011-07-11 | 2014-11-27 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
US10975149B2 (en) | 2015-12-16 | 2021-04-13 | The Walter And Eliza Hall Institute Of Medical Research | Inhibition of cytokine-induced SH2 protein in NK cells |
GB2573406B (en) | 2016-10-18 | 2021-11-10 | Univ Minnesota | Tumor infiltrating lymphocytes and methods of therapy |
US20210230548A1 (en) | 2018-05-03 | 2021-07-29 | Board Of Regents, The University Of Texas System | Natural killer cells engineered to express chimeric antigen receptors with immune checkpoint blockade |
WO2020041192A1 (en) | 2018-08-20 | 2020-02-27 | Takeda Vaccines, Inc. | Vlp formulations |
AR117462A1 (es) | 2018-12-20 | 2021-08-04 | Takeda Vaccines Inc | Vacuna contra norovirus, formulaciones y métodos |
CA3128888A1 (en) | 2019-02-15 | 2020-08-20 | Editas Medicine, Inc. | Modified natural killer (nk) cells for immunotherapy |
-
2008
- 2008-09-18 SG SG10201601660YA patent/SG10201601660YA/en unknown
- 2008-09-18 SG SG2012066726A patent/SG184733A1/en unknown
- 2008-09-18 CA CA2698397A patent/CA2698397C/en active Active
- 2008-09-18 EP EP08832560A patent/EP2190471A4/en not_active Withdrawn
- 2008-09-18 KR KR1020107008312A patent/KR20100083150A/ko active Application Filing
- 2008-09-18 JP JP2010525114A patent/JP2010539192A/ja active Pending
- 2008-09-18 AU AU2008302276A patent/AU2008302276B2/en active Active
- 2008-09-18 KR KR1020157030824A patent/KR20150129042A/ko not_active Application Discontinuation
- 2008-09-18 CN CN200880116659.6A patent/CN101918028B/zh active Active
- 2008-09-18 WO PCT/US2008/076763 patent/WO2009039229A2/en active Application Filing
- 2008-09-18 CN CN201410764410.3A patent/CN104740624B/zh active Active
- 2008-09-18 US US12/678,813 patent/US10130696B2/en active Active
-
2014
- 2014-05-02 JP JP2014095094A patent/JP6296885B2/ja active Active
-
2015
- 2015-12-14 HK HK15112279.0A patent/HK1211473A1/xx unknown
-
2016
- 2016-07-29 JP JP2016149168A patent/JP6615063B2/ja active Active
-
2019
- 2019-06-03 US US16/429,580 patent/US10688174B2/en active Active
- 2019-06-07 JP JP2019107207A patent/JP2019163328A/ja not_active Withdrawn
-
2020
- 2020-05-08 US US16/870,020 patent/US11040097B2/en active Active
-
2021
- 2021-06-15 US US17/348,045 patent/US11826415B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2014141528A (ja) | 2014-08-07 |
US11826415B2 (en) | 2023-11-28 |
US10130696B2 (en) | 2018-11-20 |
KR20100083150A (ko) | 2010-07-21 |
US11040097B2 (en) | 2021-06-22 |
AU2008302276A1 (en) | 2009-03-26 |
EP2190471A4 (en) | 2012-05-09 |
JP2016196502A (ja) | 2016-11-24 |
CA2698397C (en) | 2018-03-27 |
CA2698397A1 (en) | 2009-03-26 |
CN101918028B (zh) | 2015-01-07 |
SG10201601660YA (en) | 2016-04-28 |
EP2190471A2 (en) | 2010-06-02 |
WO2009039229A3 (en) | 2009-09-03 |
JP6615063B2 (ja) | 2019-12-04 |
US20200345827A1 (en) | 2020-11-05 |
CN104740624A (zh) | 2015-07-01 |
US20190381164A1 (en) | 2019-12-19 |
WO2009039229A2 (en) | 2009-03-26 |
JP2010539192A (ja) | 2010-12-16 |
CN104740624B (zh) | 2018-04-24 |
JP2019163328A (ja) | 2019-09-26 |
AU2008302276B2 (en) | 2013-10-10 |
CN101918028A (zh) | 2010-12-15 |
JP6296885B2 (ja) | 2018-03-20 |
US20220143169A1 (en) | 2022-05-12 |
US10688174B2 (en) | 2020-06-23 |
SG184733A1 (en) | 2012-10-30 |
US20110182975A1 (en) | 2011-07-28 |
KR20150129042A (ko) | 2015-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1211473A1 (en) | Vaccine of conferring a protective immune response to norovirus | |
EP2390894A4 (en) | ELEMENT OF PROTECTION | |
EP2211903A4 (en) | CLL-1 ANTIBODY | |
IL217008A0 (en) | Vaccine | |
EP2374053A4 (en) | VIRTUAL SIDE PAGES | |
EP2598918A4 (en) | USE OF AN ACOUSTIC SENSOR DISTRIBUTED WITH OPTICAL FIBERS TO POSITION AN OBJECT | |
PL2260153T3 (pl) | Zabezpieczenie przeciwpożarowe elementu strukturalnego | |
EP2417827A4 (en) | ATTACHING A DETECTOR TO A WSAN (WIRELESS NETWORK OF SENSORS AND ACTORS) | |
EP2381457A4 (en) | ELEMENT OF PROTECTION | |
ZA201207027B (en) | Motorcycle rear portion structure | |
EP2461670A4 (en) | PROTECTIVE CLOTHING FOR PETS | |
SI2208664T1 (sl) | Zaščita krmila | |
GB201006165D0 (en) | Vaccine | |
PT2546231T (pt) | Derivado de alquilamina | |
GB201118171D0 (en) | Improvements relating to protective chaps | |
DE112010002599T8 (de) | An einem Spannzeug befestigter Schutzschild | |
GB201000522D0 (en) | Vaccine | |
IL222506A0 (en) | Alternative to tetrazene | |
EP2395152A4 (en) | SYSTEM FOR PROTECTING MOTORCYCLISTS | |
EP2555911A4 (en) | MOLDING TOOL ASSEMBLY HAVING A RESIN HOLDING DEVICE POSITIONED RELATIVE TO A TORQUE PART | |
GB201002333D0 (en) | Hood assembly for use with a protective suit | |
IL217194A0 (en) | Vaccine | |
FR2952909B1 (fr) | Objet servant a faire des souhaits | |
GB0916571D0 (en) | Soiling protection suit | |
GB201001029D0 (en) | Improvement to optical sensor system |